Advanced search
Publication Cover
Cell Communication & Adhesion Volume 10, 2003 - Issue 1
Journal homepage
163
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Adhesion of Monocytes to Medical Steel as Used for Vascular Stents is Mediated by the Integrin Receptor Mac-1 (CD11b/CD18; α M β 2 ) and Can be Inhibited by Semiconductor Coating

Pia Schuler Department of Cardiology and Angiology, University of Freiburg, Germany
,
Dawit Assefa Department of Cardiology and Angiology, University of Freiburg, Germany
,
Jari Ylänne Biocenter Oulu, Department of Biochemistry, University of Oulu, Finland
,
Nicole Basler Department of Cardiology and Angiology, University of Freiburg, Germany
,
Manfred Olschewski Department of Biometry, University of Freiburg, Germany
,
Ingo Ahrens Department of Cardiology and Angiology, University of Freiburg, Germany
,
Thomas Nordt Department of Cardiology and Angiology, University of Freiburg, Germany
,
Christoph Bode Department of Cardiology and Angiology, University of Freiburg, Germany
&
Karlheinz Peter Department of Cardiology and Angiology, University of Freiburg, Germany
 show all
Pages 17-26 | Published online: 11 Jul 2009

  • Altieri DC, Edgington TS (1988). A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol 141:2656-2660.
  • Bayer G, Hartwig S, Nagel M, Tittelbach M, Rzany A, Schaldach M (2001). Future strategies for antiproliferative stent coatings. Prog Blamed Res 6: 1-4.
  • Benimetskaya L, Loike JD, Khaled Z, Loike G, Silverstein SC, Cao L, El Khoury J, Cai T, Stein CA (1997). Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nat Med3:414-420.
  • Coller B (1999). Potential non-glycoprotein Ilb/IIIa effects of abciximab. Am Heart J138: 51-55.
  • Duda NT, Tumelero RT, Tognon AP (2002). Silicon carbide-coated stent: Restenosis study (SlCARS). Am JCardiol90:75H.
  • ERASER Investigators (1999). Acute platelet inhibition with abciximab does not reduce instent restenosis (ERASER study). Circulation 100: 799-806.
  • Harder C, Rzany A, Schaldach M. Coating of vascular stents with antithrombogenic amorphous silicon carbide. Prog Biomed Res 4:71-77.
  • Heublein B, Ozbek C, Pethig K (1998). Silicon carbide-coated stents: Clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg 5: 32-36.
  • Horvath C, Welt FG, Nedelman M, Rao P, Rogers C (2002). Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: Inhibitory potential depends on type of injury and leukocytes targeted. Circ Res 90: 488-494.
  • Hynes RO (2002). Integrins: Bidirectional allosteric signaling machines. Cell 110: 673-687.
  • Kalnins U, Erglis A, Dinne I, Kumsars I, Jegere S (2002). Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease. Med Sci Monit 8: 16-18.
  • Koch W, BottigerC, Mehilli J, von Beckerath N, Neumann FJ, Schömig A, Kastrati A (2001). Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting. Am J Cordial 88: 1120-1124.
  • Lu CF, Springer TA (1997). The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1. J lmmunol 159: 268-278.
  • Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, and Smith CW (1996). Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease? J Am Coll Cardiol28: 345-353.
  • Monnink SH, van Boven AJ, Peels HO, Tigchelaar I, de Kam PJ, Crijns HJ, van Oeveren W (1999). Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. J Investig Med47: 304-310.
  • Ott I, Neumann FJ, Kenngott S, Gawaz M, Schömig A (1998). Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cordial 82: 938-942.
  • Peter K, O'Toole TE (1995). Modulation of cell adhesion by changes in aLß2 (LFA-1,CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J Exp Med 181: 315-326.
  • Peter K, Bode C (1996). A deletion in the a-subunit locks platelet integrin aIIbß3 into a high affinity state. Blood Coag Fibrinolysis 7: 233-236.
  • Peter K, Schwarz M, Conradt C, Nordt T, Moser M, Kübier W, Bode C (1999). Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation 100: 1533-1539.
  • Plescia J, Altieri DC (1996). Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 319: 873-879.
  • Plescia J, Conte MS, Van Meter G, Ambrosini G, Altieri DC (1998). Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphallb/beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J Biol Chem 273:20372-20377.
  • Rzany A, Schaldach M (1999). Physical properties of antithrombogenic materials--an electronic model of contact activation. Prog Blamed Res 4: 59-66.
  • Rogers C, Welt FG, Karnovsky MJ, Edelman ER (1996). Monocyte recruitment and neointimal hyperplasia in rabbits: Coupled inhibitory effects of heparin. Arterioscler Thromb Vase Biol 16: 1312-1318.
  • Rogers C, Edelman ER, Simon DI (1998). A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimai thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 95: 10134-10139.
  • Schwarz M, Nordt T, Bode C, PeterK (2002). The GPIIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, aMß2). Thromb Res 107: 121-128.
  • Simon DI, Xu H, Ortlepp S, Rogers C, Rao NV (1997). 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-I. Arterioscler Thromb Vase Biol 17: 528-535.
  • Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C (2000). Decreased neointimal formation in Mac-1 (--/--) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest 105: 293-300.
  • Springer TA (1995). Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57: 827-872.
  • Topol EJ, Serruys PW (1998). Frontiers in interventional cardiology. Circulation 98: 1802-1820.
  • Topol EJ, Byzova TV, Plow EF (1999). Platelet GPIIb-IIIa blockera. Lancet 353: 227-231.
  • Van Belle E, Tio FO, Couffinhal T, Maillard L, Passen J, Isner JM (1997). Stent endothelialization: Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 95: 438-448.
  • Van Oeveren W (1999). Reduced deposition of blood formed elements and fibrin onto amorphous silicon carbide coated stainless steel. Prog Biomed Res 4: 78-83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.